1Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev ,2008,88 (2) :451 - 487.
2Avasthi PS, Koshy V. The anionic matrix at the rat glomerular endothelial surface. Anat Rec, 1988,220 ( 3 ) : 258 - 266.
3Sorensson J, Bjornson A, Ohlson M, et al. Synthesis of sulfated proteo- glycans by bovine glomerular endothelial cells in culture. Am J Physiol Renal Physiol,2003,284 ( 2 ) : F373 - 380.
4Hjalmarsson C, Johansson BR, Haraldsson B. Electron microscopic evaluation of the endothelial surface layer of glomerular capillaries. Microvasc Res,2004,67 ( 1 ) :9 - 17.
6Jeansson M, Haraldsson B. Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol,2003,14 ( 7 ) : 1756 - 1765.
7Singh A, Satchell SC, Neal CR, et al. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol, 2007,18( 11 ) :2885 -2893.
8Jeansson M, Bjorck K, Tenstad O, et al. Adriamyein alters glomerular endotheliurn to induce proteinuria. J Am Soc Nephrol,2009,20( 1 ) : 114 - 122.
9Schnitzer JE, Carley WW, Palade GE. Specific albumin binding to microvascular endothelium in culture. Am J Physiol, 1988,254 (3 Pt 2) : H425 - 437.
10Schnitzer JE, Pinney E. Quantitation of specific binding of orosomucoid to cultured microvascular endothelium:role in capillary permeability. Am J Physiol,1992,263(1 Pt 2) :H48 -55.
二级参考文献26
1Beck LH Jr,Bonegio RG,Lambeau G,et al.M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.N Engl J Med,2009,361(1):11-21.
2Cattran DC,Greenwood C,Bitchie S,et al.A controlled trial of cyclosporine in patients with progressive membranous nephropathy.Canadian Glomerulonephritis Study Group.Kidney Int,1995,47(4):1130-1135.
3Cattran DC,Appel GB,Hebert LA,et al.Cyclosporine in patients with steroid-resistant membranous nephropathy:a randomized trial.Kidney Int,2001,59(4):1484-1490.
5Faul C,Donnelly M,Merscher-Gomez S,et al.The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.Nat Med,2008,14(9):931-938.
6Gonch JL,Pergola PE,Guler RL,et al.Differential expression of calcineurin A isoforms in the diabetic kidney.J Am Soc Nephrol,2004,15(6):1421-1429.
7Tokuyasu KT.Application of cryoultramicrotomy to immunocytochemistry.J Microsc,1986,143(Pt 2):139-149.
8Saito A,Pietromonaco S,Loo AK,et al.Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family.Proc Natl Acad Sci U S A,1994,91(21):9725-9729.
9Debiec H,Guigonis V,Mougenot B,et al.Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.N Engl J Med,2002,346(26):2053-2060.
10Ruggenenti P,Cravedi P,Sghirlanzoni MC,et al.Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.Clin J Am Soc Nephrol,2008,3(6):1652-1659.
